Literature DB >> 1759060

Pathology of the peritoneum: a review of selected topics.

D Daya1, W T McCaughey.   

Abstract

Mesothelial lesions of the peritoneum may pose significant diagnostic problems. Accurate identification of these lesions is important because of their distinctive behavior and treatment requirements. This review discusses the clinical, pathological, and differential diagnosis of a variety of mesothelial lesions of the peritoneum, which includes mesothelial hyperplasia, multilocular peritoneal inclusion cysts (benign cystic mesothelioma), well-differentiated papillary mesotheliomas, and diffuse malignant mesothelioma, and the role of immunohistochemistry in the distinction from the more common primary peritoneal serous carcinomas. In addition, borderline serous tumors, psammocarcinomas, and solitary fibrous tumors of the peritoneum are briefly mentioned.

Entities:  

Mesh:

Year:  1991        PMID: 1759060

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  14 in total

1.  Benign multicystic mesothelioma with concurrent colonic adenocarcinoma: a report of two cases.

Authors:  Anwar Husain; Metin Ozdemirli
Journal:  Surg Today       Date:  2011-12-21       Impact factor: 2.549

2.  Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Authors:  Pamela N Peters; Elizabeth M Schryver; Ernst Lengyel; Hilary Kenny
Journal:  J Vis Exp       Date:  2015-12-31       Impact factor: 1.355

3.  Ovarian cancer development and metastasis.

Authors:  Ernst Lengyel
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

4.  Fasting hypoglycemia in solitary fibrous tumor of the peritoneum: a diagnostic clue for an emergent situation.

Authors:  Gahl Greenberg; Itamar Pomeranz; Myra Shapiro-Feinberg; Rivka Zissin
Journal:  Emerg Radiol       Date:  2003-08-16

Review 5.  Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis.

Authors:  Hilary A Kenny; Songuel Dogan; Marion Zillhardt; Anirban K Mitra; S Diane Yamada; Thomas Krausz; Ernst Lengyel
Journal:  Cancer Treat Res       Date:  2009

Review 6.  Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.

Authors:  Tsz-Lun Yeung; Cecilia S Leung; Kay-Pong Yip; Chi Lam Au Yeung; Stephen T C Wong; Samuel C Mok
Journal:  Am J Physiol Cell Physiol       Date:  2015-07-29       Impact factor: 4.249

7.  MMP-2 functions as an early response protein in ovarian cancer metastasis.

Authors:  Hilary A Kenny; Ernst Lengyel
Journal:  Cell Cycle       Date:  2009-03-25       Impact factor: 4.534

8.  Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.

Authors:  Hilary A Kenny; Chun-Yi Chiang; Erin A White; Elizabeth M Schryver; Mohammed Habis; Iris L Romero; Andras Ladanyi; Carla V Penicka; Joshy George; Karl Matlin; Anthony Montag; Kristen Wroblewski; S Diane Yamada; Andrew P Mazar; David Bowtell; Ernst Lengyel
Journal:  J Clin Invest       Date:  2014-09-09       Impact factor: 14.808

9.  {beta}3-integrin expression on tumor cells inhibits tumor progression, reduces metastasis, and is associated with a favorable prognosis in patients with ovarian cancer.

Authors:  Swayamjot Kaur; Hilary A Kenny; Sujatha Jagadeeswaran; Marion R Zillhardt; Anthony G Montag; Emily Kistner; S Diane Yamada; Anirban K Mitra; Ernst Lengyel
Journal:  Am J Pathol       Date:  2009-10-01       Impact factor: 4.307

10.  MR imaging features of peritoneal adenomatoid mesothelioma: a case report.

Authors:  Cynthia Maria Coelho Lins; Jorge Elias; Adilson Ferreira Cunha; Valdair Francisco Muglia; Carlos Ribeiro Monteiro; Fábio V Valeri; Omar Feres
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.